Trial Profile
Vascular Improvement with Olmesartan medoxomil Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Feb 2024
Price :
$35
*
At a glance
- Drugs Olmesartan medoxomil (Primary) ; Atenolol
- Indications Hypertension
- Focus Pharmacodynamics
- Acronyms VIOS
- Sponsors Daiichi Sankyo Inc
- 12 Jun 2007 Status change
- 29 Nov 2006 New trial record.